FP
AMED

Foundry Partners’s Amedisys AMED Stock Holding History

Foundry Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-986
Closed -$261K – 372
2021
Q1 		$261K Sell
986
-8,729
-90% -$2.46M 0.01% 415
2020
Q4 		$2.85M Sell
9,715
-42
-0.4% -$10.8K 0.11% 228
2020
Q3 		$2.31M Buy
9,757
+339
+4% +$77.1K 0.11% 229
2020
Q2 		$1.87M Sell
9,418
-2,598
-22% -$485K 0.09% 246
2020
Q1 		$2.21M Sell
12,016
-300
-2% -$53.4K 0.12% 203
2019
Q4 		$2.06M Sell
12,316
-376
-3% -$55.9K 0.08% 264
2019
Q3 		$1.66M Sell
12,692
-125
-1% -$16.3K 0.07% 276
2019
Q2 		$1.56M Sell
12,817
-13,127
-51% -$1.56M 0.06% 287
2019
Q1 		$3.2M Sell
25,944
-4,289
-14% -$538K 0.13% 221
2018
Q4 		$3.54M Sell
30,233
-4,226
-12% -$498K 0.16% 200
2018
Q3 		$4.31M Sell
34,459
-53
-0.2% -$5.85K 0.16% 210
2018
Q2 		$2.95M Sell
34,512
-2,245
-6% -$165K 0.12% 243
2018
Q1 		$2.22M Buy
36,757
+5,790
+19% +$330K 0.09% 271
2017
Q4 		$1.63M Sell
30,967
-24,522
-44% -$1.29M 0.07% 285
2017
Q3 		$3.1M Sell
55,489
-162
-0.3% -$8.57K 0.12% 258
2017
Q2 		$3.5M Buy
+55,651
New +$3.24M 0.14% 243

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Foundry Partners's AMED Position: Q2 2021 in Review

Foundry Partners sold out of Amedisys (AMED) in Q2 2021, closing a stake of 986 shares — an estimated $261K sold.

Foundry Partners first reported a position in AMED in Q2 2017 and held it in 16 quarters. The position peaked at $4.31M in Q3 2018. 375 funds tracked by Wall St. Rank hold AMED as of Q2 2021.

  • Foundry Partners reported no remaining Amedisys position as of Q2 2021 after selling out during the quarter.
  • Foundry Partners sold 986 Amedisys shares in Q2 2021, an estimated $261K.
  • Foundry Partners first reported a position in Amedisys in Q2 2017 and held it in 16 quarters.
  • Foundry Partners's Amedisys position peaked at $4.31M in Q3 2018.
  • 375 funds tracked by Wall St. Rank held Amedisys as of Q2 2021.

Based on Foundry Partners's 13F filing for Q2 2021, filed 23 Jul 2021.